文献
J-GLOBAL ID:201802269768523346
整理番号:18A1358492
中等度から重度のプラーク性乾癬の治療におけるハロベタソールとタザロテンの固定併用の安全性と有効性:2相無作為化対照試験の結果【JST・京大機械翻訳】
Safety and efficacy of a fixed combination of halobetasol and tazarotene in the treatment of moderate-to-severe plaque psoriasis: Results of 2 phase 3 randomized controlled trials
著者 (9件):
Gold Linda Stein
(Henry Ford Hospital, Detroit, Michigan)
,
Lebwohl Mark G.
(Icahn School of Medicine at Mount Sinai, New York, New York)
,
Sugarman Jeffrey L.
(Volunteer Clinical Faculty, University of California, San Francisco, California)
,
Pariser David M.
(Virginia Clinical Research, Inc, Norfolk, Virginia)
,
Lin Tina
(Ortho Dermatologics, Bridgewater, New Jersey)
,
Martin Gina
(Dow Pharmaceutical Sciences, Inc, a division of Valeant Pharmaceuticals, North America, LLC, Petaluma, California)
,
Pillai Radhakrishnan
(Dow Pharmaceutical Sciences, Inc, a division of Valeant Pharmaceuticals, North America, LLC, Petaluma, California)
,
Israel Robert
(Valeant Pharmaceuticals, Bridgewater, New Jersey)
,
Ramakrishna Tage
(Valeant Pharmaceuticals, Bridgewater, New Jersey)
資料名:
Journal of the American Academy of Dermatology
(Journal of the American Academy of Dermatology)
巻:
79
号:
2
ページ:
287-293
発行年:
2018年
JST資料番号:
E0567B
ISSN:
0190-9622
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
オランダ (NLD)
言語:
英語 (EN)